New saliva test can detect oral cancer: Study
Team Udayavani, Dec 13, 2019, 4:45 PM IST
New York: Researchers have developed a new non-invasive method to analyse saliva for the presence of the human papilloma virus (HPV) which is associated with cancers of the mouth and throat.
The study, published in the Journal of Molecular Diagnostics, noted that the novel technique detected oropharyngeal cancers (OPCs) in whole saliva in 40 per cent of patients tested, and in 80 per cent of confirmed OPC patients.
The researchers, including those from Duke University in the US, said these cancers, which occur in the back of the mouth and upper throat, are often not diagnosed until they become advanced.
They said this is because their location makes it difficult to detect them during routine clinical exams.
“Considering these factors, the successful detection of HPV from salivary exosomes isolated by our acoustofluidic platform offers distinct advantages, including early detection, risk assessment, and screening,” said study co-author Tony Jun Huang.
The scientists said the technique may also help physicians predict which patients will respond well to radiation therapy, or achieve longer progression-free survival.
In the current study, they analysed saliva samples from 10 patients diagnosed with HPV-OPC using traditional methods.
The new method made use of the properties of tiny protein packages in the cells called exosomes.
They said these tiny microvesicles originating within cells, are secreted into body fluids.
According to the researchers, the exosomes are believed to play a role in intercellular communication and their numbers are elevated in association with several types of cancers.
To analyse the vescicles, the researchers used a technique called Acoustofluidics — an advanced technology that fuses the study of sound and fluids.
The fluid samples were analyzed using a tiny acoustofluidic chip developed to isolate salivary exosomes by removing unwanted particles based on size.
This left behind exosome-rich concentrated samples that make it easier to detect tumor-specific biomarkers.
The researchers found that the new test identified the tumor biomarker HPV-16 DNA in 80 percent of the cases when coupled with another method called droplet digit PCR.
Since this method is independent of sample variability that arises due to changes in saliva viscosity, and collection methods used, the researchers said, it may prove ideal for use in clinical settings.
“With these features, the acoustofluidic technology has the potential to significantly exceed current industry standards, address unmet needs in the field, help expedite exosome-related biomedical research, and aid in the discovery of new exosomal biomarkers,” Huang said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates
MUST WATCH
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.